HK1178142A1 - Processes for making cyclopropyl amide derivatives and intermediates associated therewith - Google Patents
Processes for making cyclopropyl amide derivatives and intermediates associated therewithInfo
- Publication number
- HK1178142A1 HK1178142A1 HK13105221.5A HK13105221A HK1178142A1 HK 1178142 A1 HK1178142 A1 HK 1178142A1 HK 13105221 A HK13105221 A HK 13105221A HK 1178142 A1 HK1178142 A1 HK 1178142A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- processes
- associated therewith
- amide derivatives
- cyclopropyl amide
- intermediates associated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/65—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/06—Preparation of carboxylic acid amides from nitriles by transformation of cyano groups into carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/14—Preparation of carboxylic acid amides by formation of carboxamide groups together with reactions not involving the carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/84—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30558310P | 2010-02-18 | 2010-02-18 | |
PCT/SE2011/050171 WO2011102794A1 (en) | 2010-02-18 | 2011-02-17 | Processes for making cyclopropyl amide derivatives and intermediates associated therewith |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1178142A1 true HK1178142A1 (en) | 2013-09-06 |
Family
ID=44370080
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK13105221.5A HK1178142A1 (en) | 2010-02-18 | 2013-04-30 | Processes for making cyclopropyl amide derivatives and intermediates associated therewith |
Country Status (20)
Country | Link |
---|---|
US (2) | US9012452B2 (ja) |
EP (2) | EP2536685B1 (ja) |
JP (3) | JP2013520414A (ja) |
KR (2) | KR20130004296A (ja) |
CN (2) | CN102869651A (ja) |
AR (2) | AR080205A1 (ja) |
AU (2) | AU2011218492B2 (ja) |
BR (2) | BR112012020629A2 (ja) |
CA (2) | CA2790040A1 (ja) |
CL (2) | CL2012002259A1 (ja) |
CO (1) | CO6592109A2 (ja) |
ES (1) | ES2541857T3 (ja) |
HK (1) | HK1178142A1 (ja) |
IL (1) | IL221431A (ja) |
MX (2) | MX336333B (ja) |
NZ (2) | NZ601920A (ja) |
RU (2) | RU2012139082A (ja) |
SG (3) | SG10201501226VA (ja) |
TW (2) | TWI520945B (ja) |
WO (2) | WO2011102794A1 (ja) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2805937A1 (en) | 2007-08-22 | 2014-11-26 | AstraZeneca AB | Cyclopropyl amide derivatives |
TW201039825A (en) | 2009-02-20 | 2010-11-16 | Astrazeneca Ab | Cyclopropyl amide derivatives 983 |
CA2790040A1 (en) | 2010-02-18 | 2011-08-25 | Astrazeneca Ab | Processes for making cyclopropyl amide derivatives and intermediates associated therewith |
SG183231A1 (en) * | 2010-02-18 | 2012-09-27 | Astrazeneca Ab | Solid forms comprising a cyclopropyl amide derivative |
FR3003466B1 (fr) * | 2013-03-22 | 2015-08-07 | Servier Lab | Utilisation du 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide pour le traitement des douleurs neuropathiques |
JP6644673B2 (ja) * | 2013-03-22 | 2020-02-12 | メルク パテント ゲーエムベーハー | 有機エレクトロルミッセンス素子のための材料の調製用の合成構築ブロック |
CN103342655A (zh) * | 2013-07-02 | 2013-10-09 | 扬州大学 | 取代乙二酮双苯胺希夫碱合成取代酰胺的新方法 |
Family Cites Families (98)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE637271A (ja) | 1963-04-04 | 1900-01-01 | ||
NL128365C (ja) | 1963-11-05 | |||
US3449427A (en) | 1965-06-03 | 1969-06-10 | Smithkline Corp | Aminocyclopropane derivatives of 5h-dibenzo(a,d)cycloheptenes |
US3697506A (en) | 1970-08-07 | 1972-10-10 | Pfizer | Crystalline alkali metal salts of {60 -carboxybenzylpenicillin and process therefor |
US3686335A (en) | 1970-12-21 | 1972-08-22 | Smith Kline French Lab | 5-vinyl-5h-di benzo(a,d)cycloheptenes |
US4432987A (en) * | 1982-04-23 | 1984-02-21 | Pfizer Inc. | Crystalline benzenesulfonate salts of sultamicillin |
US4547505A (en) | 1983-03-25 | 1985-10-15 | Degussa Aktiengesellschaft | N-Phenyl-N-'-cycloalkylalkanoylpiperazine useful as analgetics and process for its production |
CS244821B2 (en) | 1983-06-16 | 1986-08-14 | Boehringer Ingelheim Ltd | Production method of new substituted phenylalkyl(piperazinyl or homopiperazinyle)-prpylureas or thioureas |
DE3418167A1 (de) | 1984-05-16 | 1985-11-21 | Bayer Ag, 5090 Leverkusen | Verwendung von amiden zur verbesserung der kulturpflanzen-vertraeglichkeit von herbizid wirksamen heteroaryloxyacetamiden |
DE3600288A1 (de) | 1986-01-08 | 1987-07-16 | Bayer Ag | Verwendung von amiden zur verbesserung der kulturpflanzen-vertraeglichkeit von herbizid wirksamen sulfonylharnstoff-derivaten |
DE3618004A1 (de) | 1986-05-28 | 1987-12-03 | Bayer Ag | Verwendung von amiden zur verbesserung der kulturpflanzen-vertraeglichkeit von herbizid wirksamen sulfonyliso(thio)-harnstoff-derivaten |
WO1991009594A1 (en) | 1989-12-28 | 1991-07-11 | Virginia Commonwealth University | Sigma receptor ligands and the use thereof |
DE69013131T2 (de) | 1989-12-29 | 1995-05-24 | Banyu Pharma Co Ltd | 2-(2-Cyclopropylpyrrolidin-4-ylthio)carbapenemderivate. |
WO1993003615A1 (en) | 1991-08-22 | 1993-03-04 | Monsanto Company | Safening herbicidal pyrazolylsulfonylures |
DE4131139A1 (de) | 1991-09-19 | 1993-03-25 | Bayer Ag | Verfahren zur herstellung von 1-fluor-cyclopropan-1-carbonsaeure |
EP0690864B1 (en) | 1993-03-12 | 2001-06-13 | PHARMACIA & UPJOHN COMPANY | Crystalline ceftiofur free acid |
CN1088062C (zh) | 1994-11-23 | 2002-07-24 | 纽罗根公司 | 某些4-氨基甲基-2-取代的咪唑衍生物2-氨基甲基-4-取代的咪唑衍生物新的一族多巴胺受体亚型特异性配体 |
US5604253A (en) | 1995-05-22 | 1997-02-18 | Merck Frosst Canada, Inc. | N-benzylindol-3-yl propanoic acid derivatives as cyclooxygenase inhibitors |
US5859246A (en) | 1997-01-30 | 1999-01-12 | Neurogen Corporation | 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands |
AU6179998A (en) | 1997-02-24 | 1998-09-09 | Zymogenetics Inc. | Calcitonin mimetics |
US6160134A (en) | 1997-12-24 | 2000-12-12 | Bristol-Myers Squibb Co. | Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines |
EA200000768A1 (ru) | 1998-01-27 | 2001-06-25 | Эвентис Фармасьютикалз Продактс Инк. | ЗАМЕЩЕННЫЕ ОКСОАЗАГЕТЕРОЦИКЛИЧЕСКИЕ ИНГИБИТОРЫ ФАКТОРА Ха |
US6268367B1 (en) | 1998-02-23 | 2001-07-31 | Zymogenetics, Inc. | Piperazine derivatives for treating bone deficit conditions |
WO2000000492A1 (fr) | 1998-06-26 | 2000-01-06 | Chugai Seiyaku Kabushiki Kaisha | DERIVE D'ACIDE L-α-AMINOADIPIQUE EN POUDRE FINE, PREPARATIONS SOLIDES ORALES CONTENANT LEDIT DERIVE ET PROCEDE DE TRAITEMENT DE POUDRES EN VRAC |
AU771199B2 (en) | 1999-01-08 | 2004-03-18 | Neurogen Corporation | 1-phenyl-4-(1-(2-aryl)cyclopropyl) methylpiperazines: dopamine receptor ligands |
US6284761B1 (en) | 1999-01-08 | 2001-09-04 | Neurogen Corporation | 1-phenyl-4-(1-[2-aryl]cyclopropyl)methylpiperazines: dopamine receptor ligands |
GB9913083D0 (en) * | 1999-06-04 | 1999-08-04 | Novartis Ag | Organic compounds |
US6936602B1 (en) | 1999-06-16 | 2005-08-30 | Takeda Chemical Industries, Ltd. | Benzazepine derivatives, process for the preparation of the same and uses thereof |
WO2001022963A1 (en) | 1999-09-27 | 2001-04-05 | Merck & Co., Inc. | Method of preventing osteoporosis |
WO2001051919A2 (en) * | 2000-01-07 | 2001-07-19 | Transform Pharmaceuticals, Inc. | High-throughput formation, identification, and analysis of diverse solid-forms |
US6521619B2 (en) * | 2000-06-29 | 2003-02-18 | Icos Corporation | Aryl phenylcyclopropyl sulfide derivatives and their use as cell adhesion inhibiting anti-inflammatory and immune suppressive agents |
WO2002002522A1 (en) | 2000-06-29 | 2002-01-10 | Abbott Laboratories | Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
BR0112631A (pt) | 2000-07-20 | 2003-09-23 | Neurogen Corp | Composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, pacote, métodos de reduzir a condutáncia de cálcio de um receptor de capsaicina e de tratar um mamìfero e uso de um composto |
JPWO2002051781A1 (ja) | 2000-12-25 | 2004-04-22 | 味の素株式会社 | 光学活性ハロヒドリン化合物の製造方法 |
NZ527365A (en) * | 2001-02-23 | 2005-08-26 | Merck & Co Inc | N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists |
AU2002344951A1 (en) | 2001-07-02 | 2003-01-21 | Boehringer Ingelheim International Gmbh | Substituted piperazine and diazepanes as histamine h3 receptor agonists |
EP1422228A1 (en) | 2001-08-08 | 2004-05-26 | Takeda Chemical Industries, Ltd. | BENZAZEPINE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND USE |
JP2005508321A (ja) * | 2001-09-26 | 2005-03-31 | メルク エンド カムパニー インコーポレーテッド | 結晶形態のエルタペネムナトリウム |
AU2002363236A1 (en) * | 2001-10-30 | 2003-05-12 | Millennium Pharmaceuticals, Inc. | Compounds, pharmaceutical compositions and methods of use therefor |
US6861432B2 (en) | 2001-11-23 | 2005-03-01 | Schering Aktiengesellschaft | Piperazine derivatives that destabilize androgen receptors |
AU2003210055A1 (en) | 2002-03-22 | 2003-10-08 | Lg Life Sciences Ltd. | New crystalline forms of (2S)-N-5-[amino(imino)methyl]-2-thienylmethyl-1-(2R)-2-[(carboxymethyl)amino]-3,3-diphenylpropanoyl-2-pyrrolidinecarboxamide nH20 |
WO2003103666A2 (en) | 2002-06-07 | 2003-12-18 | Altana Pharma Ag | Novel 4,5-dihydro-imidazo[4,5,1-ij]quinolin-6-ones |
US20040077618A1 (en) | 2002-10-22 | 2004-04-22 | Bennani Youssef L. | Cycloalkylamides and their therapeutic applications |
US20040209858A1 (en) * | 2002-10-22 | 2004-10-21 | Bennani Youssef L. | Cycloalkylamides and their therapeutic applications |
AU2003284402A1 (en) | 2002-11-15 | 2004-06-15 | Yamanouchi Pharmaceutical Co., Ltd. | Antagonist to melanin-concentrating hormone receptor |
EP1569934B1 (en) | 2002-12-13 | 2008-01-23 | Smithkline Beecham Corporation | Cyclopropyl compounds as ccr5 antagonists |
JP2006528939A (ja) | 2003-04-23 | 2006-12-28 | グラクソ グループ リミテッド | ピペラジン誘導体ならびに神経および精神疾患の治療のためのその使用 |
DK1618092T3 (da) | 2003-05-01 | 2011-01-31 | Bristol Myers Squibb Co | Aryl-substituerede pyrazol-amidforbindelser, der er anvendelige som kinasehæmmere |
TWI339206B (en) * | 2003-09-04 | 2011-03-21 | Vertex Pharma | Compositions useful as inhibitors of protein kinases |
EP1694410B1 (en) | 2003-12-15 | 2010-04-14 | Japan Tobacco, Inc. | Cyclopropane derivatives and pharmaceutical use thereof |
BRPI0418939A (pt) | 2004-07-06 | 2008-04-08 | Xenon Pharmaceuticals Inc | derivados de nicotinamida e sua utilização como agentes terapêuticos |
AR050865A1 (es) | 2004-09-09 | 2006-11-29 | Sanofi Aventis | Derivados de 2- morfolino-4-pirimidona |
US8129377B2 (en) | 2004-09-29 | 2012-03-06 | Mitsubishi Tanabe Pharma Corporation | 6-(pyridinyl)-4-pyrimidone derivates as tau protein kinase 1 inhibitors |
DK1802307T3 (da) | 2004-10-15 | 2008-06-30 | Glaxo Group Ltd | Pyrrolidinderivater som histamin-receptor-ligander |
EP1833800A1 (en) | 2004-12-27 | 2007-09-19 | AstraZeneca AB | Pyrazolone compounds as metabotropic glutamate receptor agonists for the treatment of neurological and psychiatric disorders |
WO2006079916A1 (en) * | 2005-01-26 | 2006-08-03 | Pharmacia & Upjohn Company Llc | Thieno [2,3-d] pyrimidine compounds as inhibitors of adp-mediated platelets aggregation |
PE20061127A1 (es) | 2005-02-15 | 2006-10-21 | Glaxo Group Ltd | Derivados de propanosulfonamida que potencian el receptor de glutamato |
RU2408580C2 (ru) | 2005-02-17 | 2011-01-10 | Астеллас Фарма Инк. | Пиридильное неароматическое азотсодержащее гетероцикло-1-карбоксилатное производное |
JP2008534488A (ja) | 2005-03-25 | 2008-08-28 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | 血小板凝集阻害剤としての4−ピペラジニルチエノ[2,3−d]ピリミジン化合物 |
WO2006103545A1 (en) | 2005-03-28 | 2006-10-05 | Pharmacia & Upjohn Company Llc | 4-piperazinylthieno [2,3-d] pyrimidine compounds as platelet aggregation inhibitors |
EP1866317A1 (en) | 2005-03-28 | 2007-12-19 | Pharmacia & Upjohn Company LLC | 4-piperazinothieno [2, 3-d] pyrimidine compounds as platelet aggregation inhibitors |
CA2603041A1 (en) | 2005-03-28 | 2006-10-05 | Pharmacia & Upjohn Company Llc | 4-piperazinylthieno [2, 3-d] pyrimidine compounds as platelet aggregation inhibitors |
EP1924568A1 (en) | 2005-07-15 | 2008-05-28 | Schering Corporation | Quinazoline derivatives useful in cancer treatment |
TW200740779A (en) * | 2005-07-22 | 2007-11-01 | Mitsubishi Pharma Corp | Intermediate compound for synthesizing pharmaceutical agent and production method thereof |
CA2606004A1 (en) | 2005-08-02 | 2007-02-08 | Neurogen Corporation | Dipiperazinyl ketones and related analogues |
JP5185120B2 (ja) | 2005-09-16 | 2013-04-17 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | ヒスタミンh3受容体のモジュレーターとしてのシクロプロピルアミン |
US8158673B2 (en) | 2005-10-27 | 2012-04-17 | Pfizer Inc. | Histamine-3 receptor antagonists |
CN101300242B (zh) | 2005-10-31 | 2012-07-11 | 詹森药业有限公司 | 制备环丙基-酰胺衍生物的方法 |
US7799822B2 (en) | 2005-12-21 | 2010-09-21 | Vertex Pharmaceuticals Incorporated | Phenyl sulfonamides as modulators of ion channels |
US8119668B2 (en) | 2005-12-23 | 2012-02-21 | Nelson Erik B | Treatment methods employing histamine H3 receptor antagonists, including betahistine |
BRPI0707916A2 (pt) | 2006-01-13 | 2011-05-17 | Hoffmann La Roche | compostos, processo para a sua manufatura, composições farmacêuticas que os compreendem e uso destes compostos |
CN101384581B (zh) * | 2006-02-17 | 2013-09-18 | 弗·哈夫曼-拉罗切有限公司 | 作为5ht2/d3调节剂的苯甲酰基-哌啶衍生物 |
SG170053A1 (en) | 2006-03-01 | 2011-04-29 | Cementech Pty Ltd | Matrix for masonry elements and method of manufacture thereof |
JP2009132621A (ja) | 2006-03-13 | 2009-06-18 | Ajinomoto Co Inc | シクロプロピルアミド化合物の製造方法 |
EP2004619A1 (en) | 2006-03-23 | 2008-12-24 | Amgen Inc. | 1-phenylsulfonyl-diaza heterocyclic amide compounds and their uses as modulators of hydroxsteroid dehydrogenases |
US7834190B2 (en) | 2006-05-26 | 2010-11-16 | Kaneka Corporation | Process for production of optically active-3-amino-2-hydroxypropionic cyclopropylamide derivatives and salts thereof |
US9108948B2 (en) | 2006-06-23 | 2015-08-18 | Abbvie Inc. | Cyclopropyl amine derivatives |
CN103382174A (zh) | 2006-06-23 | 2013-11-06 | 雅培制药有限公司 | 作为组胺h3受体调节物的环丙胺衍生物 |
AU2007271187A1 (en) | 2006-07-03 | 2008-01-10 | Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg | Fused bicyclic compounds interacting with the histamine H4 receptor |
GB0615620D0 (en) * | 2006-08-05 | 2006-09-13 | Astrazeneca Ab | A process for the preparation of optically active intermediates |
US20090247499A1 (en) | 2006-08-21 | 2009-10-01 | Fletcher Joan M | Sulfonylated piperazines as cannabinoid-1 receptor modulators |
TW200828371A (en) | 2006-09-21 | 2008-07-01 | Matsushita Electric Ind Co Ltd | Chip-type filter |
DE102006056526A1 (de) * | 2006-11-30 | 2008-06-05 | Archimica Gmbh | Verfahren zur stereoselektiven Synthese von chiralen Epoxiden durch ADH-Reduktion von alpha-Abgangsgruppen-substituierten Ketonen und Cyclisierung |
US7737149B2 (en) | 2006-12-21 | 2010-06-15 | Astrazeneca Ab | N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof |
WO2008147864A2 (en) | 2007-05-22 | 2008-12-04 | Xenon Pharmaceuticals Inc. | Methods of using piperazine compounds in treating sodium channel-mediated diseases or conditions |
EP2150115B1 (en) | 2007-05-23 | 2013-09-18 | Merck Sharp & Dohme Corp. | Cyclopropyl pyrrolidine orexin receptor antagonists |
CN101679331A (zh) | 2007-06-11 | 2010-03-24 | 霍夫曼-拉罗奇有限公司 | 环己基衍生物 |
EP2805937A1 (en) * | 2007-08-22 | 2014-11-26 | AstraZeneca AB | Cyclopropyl amide derivatives |
EP2207540B1 (en) * | 2007-10-04 | 2014-02-26 | F. Hoffmann-La Roche AG | Cyclopropyl aryl amide derivatives and uses thereof |
CL2009000004A1 (es) * | 2008-01-15 | 2010-02-19 | Lilly Co Eli | Forma cristalina de r-2-(4-ciclopropansulfonil-fenil)-n-pirazin-2-il-3-(tetrahidropiran-4-il)-propionamida; composicion farmaceutica que comprende a dicha forma cristalina; y uso para el tratamiento de diabetes o hiperglicemia. |
DE102008049371A1 (de) | 2008-03-06 | 2009-09-10 | Mühlbauer Ag | Einrichtung mit einem RFID-Transponder in einem elektrisch leitfähigen Gegenstand und Herstellungsverfahren hierfür |
CA2718993A1 (en) * | 2008-03-20 | 2009-09-24 | Forest Laboratories Holdings Limited | Novel piperazine derivatives as inhibitors of stearoyl-coa desaturase |
WO2009135842A1 (en) | 2008-05-08 | 2009-11-12 | Evotec Neurosciences Gmbh | Azetidines and cyclobutanes as histamine h3 receptor antagonists |
EP2313360B1 (en) | 2008-07-28 | 2012-09-05 | Syddansk Universitet | Compounds for the treatment of metabolic diseases |
CN101462980B (zh) | 2009-01-05 | 2013-01-09 | 扬州天辰精细化工有限公司 | 2,6—二氟苯甲酰胺的工业化生产方法 |
TW201039825A (en) * | 2009-02-20 | 2010-11-16 | Astrazeneca Ab | Cyclopropyl amide derivatives 983 |
CA2790040A1 (en) * | 2010-02-18 | 2011-08-25 | Astrazeneca Ab | Processes for making cyclopropyl amide derivatives and intermediates associated therewith |
SG183231A1 (en) | 2010-02-18 | 2012-09-27 | Astrazeneca Ab | Solid forms comprising a cyclopropyl amide derivative |
-
2011
- 2011-02-17 CA CA 2790040 patent/CA2790040A1/en not_active Abandoned
- 2011-02-17 KR KR20127024174A patent/KR20130004296A/ko not_active Application Discontinuation
- 2011-02-17 WO PCT/SE2011/050171 patent/WO2011102794A1/en active Application Filing
- 2011-02-17 MX MX2012009480A patent/MX336333B/es unknown
- 2011-02-17 EP EP20110744974 patent/EP2536685B1/en not_active Not-in-force
- 2011-02-17 RU RU2012139082/04A patent/RU2012139082A/ru not_active Application Discontinuation
- 2011-02-17 BR BR112012020629A patent/BR112012020629A2/pt not_active IP Right Cessation
- 2011-02-17 MX MX2012009473A patent/MX2012009473A/es active IP Right Grant
- 2011-02-17 CN CN2011800196365A patent/CN102869651A/zh active Pending
- 2011-02-17 RU RU2012136148/04A patent/RU2012136148A/ru not_active Application Discontinuation
- 2011-02-17 US US13/579,605 patent/US9012452B2/en not_active Expired - Fee Related
- 2011-02-17 SG SG10201501226VA patent/SG10201501226VA/en unknown
- 2011-02-17 WO PCT/SE2011/050172 patent/WO2011102795A1/en active Application Filing
- 2011-02-17 KR KR20127021548A patent/KR20130002316A/ko not_active Application Discontinuation
- 2011-02-17 JP JP2012553850A patent/JP2013520414A/ja active Pending
- 2011-02-17 NZ NZ60192011A patent/NZ601920A/en not_active IP Right Cessation
- 2011-02-17 EP EP11744975.1A patent/EP2536702A4/en not_active Withdrawn
- 2011-02-17 BR BR112012020782A patent/BR112012020782A2/pt not_active IP Right Cessation
- 2011-02-17 AR ARP110100486 patent/AR080205A1/es unknown
- 2011-02-17 US US13/029,362 patent/US20110201623A1/en not_active Abandoned
- 2011-02-17 CA CA 2788444 patent/CA2788444A1/en not_active Abandoned
- 2011-02-17 SG SG2012055240A patent/SG182732A1/en unknown
- 2011-02-17 TW TW100105296A patent/TWI520945B/zh not_active IP Right Cessation
- 2011-02-17 NZ NZ60211011A patent/NZ602110A/en not_active IP Right Cessation
- 2011-02-17 ES ES11744974.4T patent/ES2541857T3/es active Active
- 2011-02-17 AU AU2011218492A patent/AU2011218492B2/en not_active Ceased
- 2011-02-17 AU AU2011218491A patent/AU2011218491C1/en not_active Ceased
- 2011-02-17 SG SG2012059473A patent/SG183274A1/en unknown
- 2011-02-17 AR ARP110100485 patent/AR080204A1/es unknown
- 2011-02-17 CN CN201180019632.7A patent/CN103168027B/zh not_active Expired - Fee Related
- 2011-02-17 TW TW100105300A patent/TWI494301B/zh not_active IP Right Cessation
- 2011-02-17 JP JP2012553849A patent/JP2013520413A/ja not_active Ceased
-
2012
- 2012-08-13 IL IL221431A patent/IL221431A/en not_active IP Right Cessation
- 2012-08-16 CL CL2012002259A patent/CL2012002259A1/es unknown
- 2012-08-17 CL CL2012002286A patent/CL2012002286A1/es unknown
- 2012-08-17 CO CO12140266A patent/CO6592109A2/es unknown
-
2013
- 2013-04-30 HK HK13105221.5A patent/HK1178142A1/xx not_active IP Right Cessation
-
2015
- 2015-08-14 JP JP2015160029A patent/JP2016006103A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20170961T1 (hr) | Postupak dobivanja karbamoilpiridonskih derivata i međuprodukata | |
GB201006340D0 (en) | Synthesis method and intermediates | |
EP2640730A4 (en) | METHODS FOR PREPARING EVEROLIMUS AND INTERMEDIATES THEREOF | |
ZA201108502B (en) | Processes and intermediates | |
ZA201302670B (en) | Process for the manufacture of degarelix and its intermediates | |
PT2632934T (pt) | Processo para o fabrico de degarelix e seus intermediários | |
PL2627656T3 (pl) | Sposób wytwarzania dihydropterydynonów i ich produktów pośrednich | |
EP2526099A4 (en) | IMPROVED METHOD FOR THE MANUFACTURE OF AMID INTERMEDIATE PRODUCTS AND ITS APPLICATION | |
HK1178142A1 (en) | Processes for making cyclopropyl amide derivatives and intermediates associated therewith | |
IL221441A0 (en) | Process for preparing entecavir and its intermediates | |
EP2630143A4 (en) | PROCESS FOR THE PRODUCTION OF RIVAROXABAN AND INTERMEDIATE PRODUCTS THEREOF | |
IL223067A0 (en) | Processes and intermediates | |
IL221430A0 (en) | Solid forms comprising a cyclopropyl amide derivative | |
IL229426A0 (en) | processes and intermediates | |
GB201117416D0 (en) | Processes and intermediates | |
GB201010223D0 (en) | Method of printing | |
IL243320A0 (en) | Intermediates of teroarylpiperidine and piperazine derivatives | |
GB201017214D0 (en) | Processes and intermediates | |
GB201017117D0 (en) | Processes and intermediates | |
GB201017059D0 (en) | Processes and intermediates |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20190223 |